GeoVax received a Nasdaq notice on July 7, 2026 for failing the $2.5 million minimum stockholders’ equity requirement under Listing Rule 5550(b)(1).
It also did not qualify under alternative continued-listing standards tied to market value of listed securities or net income from continuing operations.
The shares continue to trade on Nasdaq as GOVX; the notice has no immediate effect on the listing.
A compliance plan is due by Aug. 21, 2026; Nasdaq staff may grant up to a 180-day extension from the notice date if accepted.
If the plan is rejected or compliance is not regained, Nasdaq staff can move to delist; a hearing request would stay delisting.